DexCom, Inc. - Common Stock (NQ:DXCM)

86.89 +1.53 (+1.79%)

Delayed Quote Updated: 3:40 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

50 51 Next >

Forecasting The Future: 13 Analyst Projections For DexCom ↗

October 21, 2025

Via Benzinga

2 Stocks Down 17% and 21% to Buy Right Now ↗

October 14, 2025

Both companies have faced recent challenges, but look likely to overcome them.

Via The Motley Fool

Topics World Trade

Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring Segment

October 13, 2025

Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q2 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

Dexcom Inc (NASDAQ:DXCM) Fits the Affordable Growth Strategy with Solid Expansion and Sensible Pricing ↗

October 11, 2025

Dexcom offers strong growth in diabetes care with solid profitability and a reasonable valuation, fitting an affordable growth investment strategy.

Via Chartmill

DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

DexCom Stock Slumps 10% After Hunterbrook Media Investigation Raises Concerns About Its G7 Device ↗

September 19, 2025

Via Stocktwits

1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm

October 07, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.

October 02, 2025

From DexCom, Inc.

Via Business Wire

Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday? ↗

October 01, 2025

Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat.

Via Benzinga

Which S&P500 stocks are moving on Wednesday? ↗

October 01, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

October 01, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Stay informed with the top movers within the S&P500 index on Friday. ↗

September 26, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Forecasting The Future: 10 Analyst Projections For DexCom ↗

September 26, 2025

10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM

September 24, 2025

From Pomerantz LLP

Via GlobeNewswire

1 Growth Stock Down 40% to Buy Hand Over Fist Right Now ↗

September 23, 2025

It is dealing with some short-term issues, but its prospects remain bright.

Via The Motley Fool

Topics World Trade

2 Mid-Cap Stocks with Promising Prospects and 1 Facing Challenges

September 23, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

Topics Economy

Which Stocks Win When Rates Fall? Goldman Picks These Surprising Names ↗

September 22, 2025

Via Benzinga

Darden, Humana, And Rocket Lab Are Among Top 10 Large Cap Losers Last Week (Sep. 15- Sep. 19): Are The Others In Your Portfolio? ↗

September 21, 2025

Darden, Humana, Rocket Lab, and FactSet led last week's large-cap losers, with declines driven by weak earnings, guidance, and downgrades.

Via Benzinga

DEXCOM INC (NASDAQ:DXCM) Fits the Affordable Growth Investment Strategy ↗

September 20, 2025

DexCom (DXCM) offers strong growth, high profitability, and reasonable valuation, fitting the "Affordable Growth" investment strategy for long-term gains.

Via Chartmill

The Healthcare Horizon: Navigating Innovation, Policy Shifts, and Evolving Patient Care

September 19, 2025

The global healthcare industry is currently in the midst of a profound metamorphosis, characterized by a rapid influx of technological innovation, significant shifts in policy, and evolving patient...

Via MarketMinute

Topics Artificial Intelligence

Friday's session: top gainers and losers in the S&P500 index ↗

September 19, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

Small-Cap and Value Stocks Stage a Powerful Comeback: A Market Rebalancing Act Underway

September 19, 2025

After years of being overshadowed by their large-cap growth counterparts, small-cap and value stocks are experiencing a significant resurgence, signaling a potential seismic shift in market leadership....

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Wall Street Extends Gains, Apple Jumps To Highest Since February: What's Moving Markets Friday? ↗

September 19, 2025

Wall Street kept driving equity valuations higher on Friday, extending the momentum from Thursday when all major U.S. benchmarks closed at record highs following the Federal Reserve's rate cut.

Via Benzinga

Topics Economy

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

September 19, 2025

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

Via Chartmill

Uncover the latest developments among S&P500 stocks in today's session. ↗

September 19, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

Why DexCom (DXCM) Shares Are Trading Lower Today

September 19, 2025

Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring...

Via StockStory

What's going on in today's session: S&P500 gap up and gap down stocks ↗

September 19, 2025

Looking for the S&P500 stocks that are experiencing notable gaps on Friday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.

Via Chartmill

These S&P500 stocks are moving in today's session ↗

September 18, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA ↗

September 18, 2025

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from Abbott's Libre 3.

Via Benzinga

These S&P500 stocks are gapping in today's session ↗

September 18, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.

Via Chartmill

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.